Binge eating disorder: The search for better treatments

American Journal of Psychiatry

Volumn 165, Issue 1, 2008, Pages 4-6

  Yager, Joel ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SIBUTRAMINE; TOPIRAMATE; ZONISAMIDE; ANOREXIGENIC AGENT; ANTIOBESITY AGENT; CYCLOBUTANE DERIVATIVE; DRUG DERIVATIVE; FRUCTOSE; NEUROTRANSMITTER UPTAKE INHIBITOR;

ALCOHOLISM; ANXIETY DISORDER; BINGE EATING DISORDER; BODY WEIGHT; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; CONSTIPATION; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HEADACHE; HUMAN; HYPERTENSION; LONG TERM CARE; MAJOR DEPRESSION; OBESITY; PANIC; PARESTHESIA; PREVALENCE; PRIORITY JOURNAL; PSYCHOTHERAPY; SUBSTANCE ABUSE; XEROSTOMIA; BULIMIA; COMPARATIVE STUDY; FEMALE; MALE; NOTE; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; STATISTICS; TREATMENT OUTCOME;

ANTI-OBESITY AGENTS; APPETITE DEPRESSANTS; BULIMIA NERVOSA; COMORBIDITY; CYCLOBUTANES; FEMALE; FRUCTOSE; HUMANS; MALE; NEUROTRANSMITTER UPTAKE INHIBITORS; OBESITY; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 39049172714     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2007.07101541     Document Type: Editorial

References (11)

1. Hudson JI, Hiripi E, Pope HG Jr, Kessler RC: The prevalence and correlates of eating disorders in the National Comorbidity Survey replication. Biol Psychiatry 2007; 61:348-358
2. Striegel-Moore RH, Cachelin FM, Dohm FA, Pike KM, Wilfley DE, Fairburn CG: Comparison of binge eating disorder and bulimia nervosa in a community sample. Int J Eat Disord 2001; 29:157-165
3. Grucza RA, Przybeck TR, Cloninger CR: Prevalence and correlates of binge eating disorder in a community sample. Compr Psychiatry 2007; 48:124-131
4. Brownley KA, Berkman ND, Sedway JA, Lohr KN, Bulik CM: Binge eating disorder treatment: a systematic review of randomized controlled trials. Int J Eat Disord 2007; 40:337-348
5. Wirth A, Krause J: Long-term weight loss with sibutramine: a randomized controlled trial. JAMA 2001; 286:1331-1339
6. Mathus-Vliegen EM, Balance Study Group: Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study. Eur J Clin Nutr 2005; 59(suppl 1):S31-S8
7. Fanghänel G, Cortinas L, Sánchez-Reyes L, Berber A: Second phase of a double-blind study clinical trial on sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-over. Int J Obes Relat Metab Disord 2001; 25:741-747
8. Ioannides-Demos LL, Proietto J, Tonkin AM, McNeil JJ: Safety of drug therapies used for weight loss and treatment of obesity. Drug Saf 2006; 29:277-302
9. Padwal R, Kezouh A, Levine M, Etminan M: Long-term persistence with orlistat and sibutramine in a population-based cohort. Int J Obes (Lond) 2007; 31:1567-1570
10. American Psychiatric Association: Practice Guideline for the Treatment of Patients With Eating Disorders, Third Edition. Am J Psychiatry 2006; 163(July suppl):4-54
11. Niego SH, Kofman MD, Weiss JJ, Geliebter A: Binge eating in the bariatric surgery population: a review of the literature. Int J Eat Disord 2007; 40:349-359